OmniSYS Acquires Rx-Net, Taking Over $4 Billion in Annual Prescription Volume

Recently, VCBeat (WeChat ID: vcbeat) learned from foreign media reports that tech company OmniSYS has announced the acquisition of Rx-Net, an automated pharmacy pricing platform. No financial terms of the transaction were disclosed.

Rx-Net, founded in 1997 and headquartered in Kansas, USA, has revolutionized pharmacy pricing by providing automated, personalized pricing strategies that help pharmacies increase profits and improve operational efficiency. Its automated pricing solution, ProfitMax, integrates with most pharmacy management systems, enabling pharmacists to conveniently access drug pricing information without additional workflow steps. The company manages an annual prescription volume exceeding $4 billion, with customers across all 50 U.S. states.

ProfitMax provides retail pharmacies with a fully automated, single-interface, multi-region prescription pricing management service. Leveraging client-specific pricing objectives, third-party payer reimbursement mechanisms, and market data sources, ProfitMax helps pharmacies automatically set and adjust the Usual & Customary (U&C) prices of medications, thereby maximizing consumer reimbursement amounts while maintaining low prices and high profit margins.

OmniSYS, founded in 1988 and headquartered in Texas, USA, is led by its CEO, John King, and focuses on providing innovative solutions for the retail pharmacy industry. The company is a recognized leader in Medicare reimbursement and compliance services in the United States, serving pharmacies, home medical equipment (HME/DME) companies, retiree health plan organizations, and pharmacy benefit managers. OmniSYS’s product portfolio delivers comprehensive Medicare, Medicaid, clinical, and other specialized drug reimbursement services to over 35,000 companies, processing more than 40 million claims annually across all 50 states.

OmniSYS leverages its market insights, pharmacy workflow expertise, and comprehensive industry knowledge to provide medical billing reimbursement, immunization, and patient communication solutions for pharmacies, pharmaceutical companies, and consumers, and has partnered with more than 25,000 pharmacies.

John King stated, “Pharmacies are under immense pressure regarding their financial performance. Although cash-pay prescriptions typically account for less than 10% of a pharmacy’s prescription volume, they contribute 25% or more of its profits. By leveraging market intelligence and proven proprietary analytics, ProfitMax not only automates price management but also enhances pharmacy performance by ensuring profitability while offering competitive drug prices. Spot pricing—a regional price determined through fair negotiations between buyers and sellers for actual goods—is one of the few variables pharmacies can control and is closely tied to their growth. Rx-Net’s ability to create value for pharmacies and their customers through ProfitMax is compelling, which is why we are delighted to welcome them into the OmniSYS family.”

Upon completion of the acquisition, Rx-Net’s core team will join OmniSYS to facilitate business integration between Rx-Net and OmniSYS, ensuring a seamless transition for Rx-Net’s existing customers to OmniSYS.

(Compiled by Tang Lulu)